Abstract
EDITOR, — J F Smyth and colleagues outlined the problems in obtaining funding for clinical trials since the advent of the purchaser-provider split.1 The crux of the paper was that hospitals can no longer afford to subsidies clinical trials as they cannot be assured that the real cost of undertaking trials will be recouped from purchasers. It might be helpful to examine this from a purchaser's perspective. Stockport Health Commission has recently been faced with the …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
